Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes-Reference-Cited by-同舟云学术

Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes

Published:2021-12-01 Issue:12 Volume:6 Page:1371
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Yoneda Zachary T.¹,Anderson Katherine C.¹,Quintana Joseph A.¹,O’Neill Matthew J.²,Sims Richard A.¹,Glazer Andrew M.³,Shaffer Christian M.³,Crawford Diane M.¹,Stricker Thomas⁴,Ye Fei⁵,Wells Quinn¹,Stevenson Lynne W.¹,Michaud Gregory F.¹,Darbar Dawood⁶,Lubitz Steven A.⁷⁸,Ellinor Patrick T.⁷⁸,Roden Dan M.¹³⁹¹⁰,Shoemaker M. Benjamin¹

Affiliation:

1. Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee

2. Vanderbilt University School of Medicine, Nashville, Tennessee

3. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee

4. Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee

5. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee

6. Division of Cardiology, Department of Medicine, University of Illinois at Chicago, Chicago

7. Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts

8. Cardiovascular Research Center, Massachusetts General Hospital, Boston

9. Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee

10. Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2783693/jamacardiology_yoneda_2021_oi_210059_1637772536.16383.pdf

Reference47 articles.

1. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).;Ackerman;Heart Rhythm,2011

2. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.;January;Circulation,2014

3. Genetic testing for early onset atrial arrhythmias changes clinical management: 2 cases of cardiac emerinopathy.;Yoneda;JACC Clin Electrophysiol,2021

4. Broad genetic testing in a clinical setting uncovers a high prevalence of titin loss-of-function variants in very early onset atrial fibrillation.;Goodyer;Circ Genom Precis Med,2019

5. Association between titin loss-of-function variants and early-onset atrial fibrillation.;Choi;JAMA,2018

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilidad del estudio genético en la fibrilación auricular de inicio precoz;REC: CardioClinics;2024-09

2. Ablation for Atrial Fibrillation in Patients With Rare Pathogenic Variants in Cardiomyopathy and Arrhythmia Genes;JACC: Clinical Electrophysiology;2024-09

3. Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk;JAMA Cardiology;2024-08-01

4. Titin truncating variants, cardiovascular risk factors and the risk of atrial fibrillation and heart failure;Nature Cardiovascular Research;2024-07-31

5. Innovative approaches to atrial fibrillation prediction: should polygenic scores and machine learning be implemented in clinical practice?;Europace;2024-07-29